Tag Archives: T-cell Lymphoma

FDA Raises Concerns Over Carvykti and Abecma Clinical Trial Deaths Ahead of CAR-T Advisory Hearing

March 15, 2024 By: Irvin Jackson

Briefing documents filed ahead of an advisory committee meeting warns about potential side effects of Carvykti and Abecma that emerged during clinical trials, following deaths of myeloma patients.

CAR-T Therapy Drug Cancer Risks Will Be Reviewed at FDA Advisory Committee Meeting Next Month

February 07, 2024 By: Irvin Jackson

Observers are waiting to see how the FDA approaches CAR-T therapy safety risks following recently added black box warnings about new cancers.

FDA Found 22 Cases of Cancer Linked to CAR-T Treatments: Report

January 26, 2024 By: Irvin Jackson

Genetic sequencing appears to confirm that some cases of cancer have a direct connection to CAR-T cell transgenes used in the medications, the FDA reports.

CELLEX Photopheresis System May Cause Pulmonary Embolism, Death, FDA Warns

February 07, 2018 By: Irvin Jackson